Incyte Genomics, Inc. (INCY)
NGS · Common · CUSIP 45337C102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for INCY and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
45337C102
Market Cap
Large Cap
Previous Name
Incyte Pharmaceuticals, Inc.
Business: Incyte’s mission is to become one of the leading global oncology companies. Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology.

Company Contact

CEO
Hervé Hoppenot
CFO
Christiana Stamoulis
Headquarters
1801 Augustine Cut-Off, Wilmington, DE 19803
Phone
302-498-6700 · Toll-Free 855-446-2983
Fax
302-425-2707
Investor Relations
Ben Strain · 302-274-4779 · IR@incyte.com
SEC EDGAR Filings
View filings »